Firas Aljabery

Linköping University Hospital, Linköping University

Papers

8

Total Citations

62

H-Index

4

About

Dr. Firas Aljabery is a leading urologic oncologist and researcher whose work centers on improving surgical outcomes for bladder and upper tract urothelial cancers. His major contributions lie in leveraging large, nationwide population-based databases—most notably the Bladder Cancer Data Base Sweden (BladderBaSe) 2.0, which he helped construct to enable comprehensive studies on incidence, treatment, and survival. Through this resource, Dr. Aljabery has produced high-impact comparative effectiveness research, including a pivotal 2023 study comparing short-term outcomes after robot-assisted versus open radical cystectomy, cited 9 times. He has also investigated critical postoperative complications, such as the cumulative incidence of midline incisional hernia and vaginal events following cystectomy, providing surgeons with evidence to refine patient counseling and technique. His work on port-site metastases and stapled versus robot-sewn anastomoses addresses key technical debates in robotic surgery. With over 60 citations across his most-cited papers, Dr. Aljabery’s research is shaping modern urologic oncology by translating real-world data into actionable insights that improve patient safety and quality of life after major cancer surgery.

Research Focus

Key Achievements

4
H-Index
8
Papers
62
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias?
16 citations · 2017
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Linköping University Hospital, Linköping University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago